what could possibly go wrong? Not to spoil the party,I pardy hardy,given I own aprox 1% of the company., but balance implyies one sees both sides with equal clarity.
First a fresh look at the bulls side to keep the vibes up there. The intention to submit a patent does not reveal our hand...very important at this stage..patents secure rewards, but patents also tell the reverse engineers exactly what we have....not the best plan when China and others want a see what we have, Our patent attorneys are savy.
From todays news ...new licencing opportunities are obvious given this tech uses a natural delivery system...effortlessly. ( I love that word, sees like TLT uses it often :-) Some genetics dudes use viruses to deliver their payload...in the bloodstream...what could go wrong with that ?
The delay on the TL2000 might be a good thing, if we meet the new.. more stingent requiements. I don't know this takes.but .time is money! Obviouslly not good for the immediate cash flow...but the new international standard have raised the bar...might get rid of the wanna be cold laser manufacturers. As all of the lilt therapy systems offer healing benefits, the buyers get overloaded with data, it takes time for the cream to rise to the top.
The Bear side.. The rat datta was not 100% ..and the sp action was down, traders taking doubles, some expecting more or better news ...doesn't matter, down is down.. On rat bladder pics there were some pesky specks on but Not inside of the health tissue ...which Toledo is studying carefully. We need to understand the process fully to control it...could a spec of stray PDC's blow a hole in the bladder lining? I would really like a second opinion on this.
Could others produce better PDCs than ours.? Our PDC patent applications give the competition a view of what we have...not necessarily how we make them...but the chemical structure of what they are. In short, the more natural the compound, the more difficult they are to reproduce.. We trust in the strength of those patents...something few of us really understand. Patents are not very relevant until the mid stages of a buis plan, so this concern won't matter for some time. I hope.
The revenue potential of our new tech is puny compaired to the revenue potential of an effective new ...off the shelf drug.cure for cancer... But no one has one, nor are they likely to ever get one. my bias...the recent MD Anderson, ZIOP, XON is just just starting to get valued as if they have a shot at one..good trading opportunities there....but.they are less proven and more complx.than the TLT aproach..
Theralase represents a more natural aproach to treat cancer . pain and therapy. The world says they want the natural path....but they buy pills if an authority figure says so.....most people in the world favour the convcenience and massive cash flows from off the shelf drugs. Maybe this explains the TLT stock price..... these markets are so huge...evern if TLT gets a small piece of the pie....well, ....do you own math.